Follow
Simran Maggo
Simran Maggo
Childrens Hospital Los Angeles
Verified email at chla.usc.edu
Title
Cited by
Cited by
Year
Clinical implications of pharmacogenetic variation on the effects of statins
SDS Maggo, MA Kennedy, DWJ Clark
Drug Safety 34, 1-19, 2011
922011
Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand
M Harrison-Woolrych, S Maggo, M Tan, R Savage, J Ashton
Drug safety 35, 33-43, 2012
442012
Pharmacogenetics of statin-induced myotoxicity
PS Kee, PKL Chin, MA Kennedy, SDS Maggo
Frontiers in Genetics 11, 575678, 2020
392020
Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications
Y Liau, S Maggo, AL Miller, JF Pearson, MA Kennedy, SL Cree
Pharmacogenomics 20 (14), 1033-1047, 2019
382019
Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia
JR Rivers, SDS Maggo, JC Ashton
NeuroReport 23 (3), 134-138, 2012
262012
Impact of new genomic technologies on understanding adverse drug reactions
SDS Maggo, RL Savage, MA Kennedy
Clinical Pharmacokinetics 55, 419-436, 2016
242016
Pharmacogenetics of angiotensin‐converting enzyme inhibitor‐induced angioedema
Y Liau, I Chua, MA Kennedy, S Maggo
Clinical & Experimental Allergy 49 (2), 142-154, 2019
202019
Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig
S Maggo, JC Ashton
European journal of pharmacology 723, 294-304, 2014
172014
The Three Ps: psychiatry, pharmacy, and pharmacogenomics, a brief report from New Zealand
SDS Maggo, KLV Sycamore, AL Miller, MA Kennedy
Frontiers in psychiatry 10, 690, 2019
142019
Common CYP2D6, CYP2C9, and CYP2C19 gene variants, health anxiety, and neuroticism are not associated with self-reported antidepressant side effects
S Maggo, MA Kennedy, ZA Barczyk, AL Miller, JJ Rucklidge, RT Mulder, ...
Frontiers in Genetics 10, 1199, 2019
122019
A New Zealand platform to enable genetic investigation of adverse drug reactions
SDS Maggo, EW Chua, P Chin, S Cree, J Pearson, M Doogue, ...
The New Zealand Medical Journal (Online) 130 (1466), 62-69, 2017
122017
The effect of statins on performance in the Morris water maze in guinea pig
S Maggo, D Clark, JC Ashton
European journal of pharmacology 674 (2-3), 287-293, 2012
122012
Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population
A Adehin, OO Bolaji, S Maggo, MA Kennedy
Drug Metabolism and Personalized Therapy 32 (1), 39-47, 2017
102017
Long fragment polymerase chain reaction
EW Chua, S Maggo, MA Kennedy
PCR: Methods and Protocols, 65-74, 2017
102017
Personalised prescribing in psychiatry: Has pharmacogenomics delivered on its promise?
JA Foulds, SDS Maggo, MA Kennedy
Australian & New Zealand Journal of Psychiatry 50 (6), 509-510, 2016
102016
Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus
PS Kee, SDS Maggo, MA Kennedy, ML Barclay, AL Miller, K Lehnert, ...
Frontiers in Genetics 13, 869160, 2022
92022
The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses
PS Kee, SDS Maggo, MA Kennedy, PKL Chin
Frontiers in Pharmacology 14, 1080117, 2023
52023
A proof-of-principle study of the short-term effects of 3, 4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity
GD Searchfield, T Poppe, M Durai, M Jensen, MA Kennedy, S Maggo, ...
International Journal of Neuroscience 130 (7), 671-682, 2020
52020
A multiplex pharmacogenetics assay using the MinION nanopore sequencing device
Y Liau, SL Cree, S Maggo, AL Miller, JF Pearson, PA Gladding, ...
Pharmacogenetics and Genomics 29 (9), 207-215, 2019
52019
Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria
S Maggo, JC Ashton
Journal of cardiovascular pharmacology 72 (4), 191-194, 2018
52018
The system can't perform the operation now. Try again later.
Articles 1–20